ArticleCureus2026
Vaginal Perforations After Fecal Management System Use in Critically Ill Patients: A Case Series.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fecal incontinence is a relatively common condition in patients admitted to the intensive care unit (ICU). Fecal management systems (FMS) were developed to divert stool away from the skin. While they have benefits, rare but serious complications can occur. This case series discusses two cases of vaginal perforations following FMS use in critically ill patients. An 87-year-old female was admitted twice to the ICU for infective endocarditis and bacterial pneumonia. During her second ICU stay, an FMS device was in place for up to 19 days, after which a vaginal perforation with stool leakage from the vagina was noted. In the second case, a 34-year-old female was admitted following disseminated intravascular coagulation (DIC) from a likely amniotic fluid embolism. An FMS was in situ for four days before a vaginal perforation, with stool leakage from the vagina, occurred. In both cases, neither patient was stable for an exam under anesthesia with possible repair, and therefore conservative management was pursued. Vaginal perforations can occur with FMS, and healthcare workers should be aware of this possible complication. Critically ill patients are at greater risk due to comorbid conditions that may impair tissue integrity, lead to possible fistula formation, and impede successful repair. While currently not listed in manufacturer guidelines, coagulopathies, including DIC, may be considered a relative contraindication for FMS use. Like other medical devices, FMS should be monitored for correct indication and proper placement and be regularly reassessed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.